Kennedy, N., Goodhand, J., Bewshea, C., Nice, R., Chee, D., Lin, S., Chanchlani, N., Butterworth, J., Cooney, R., Croft, N., Hart, A., Irving, P., Kok, K., Lamb, Christopher A., Limdi, J., MacDonald, J., McGovern, D., Mehta, S., Murray, C., Patel, K., Pollok, R., Raine, T., Russell, R., Selinger, C., Smith, P., Bowden, J., McDonald, T., Lees, C., Sebastian, S., Powell, N. & Ahmad, T. 2021, 'Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab', Gut, 70(5), pp. 865-875. http://dx.doi.org/10.1136/gutjnl-2021-324388